Miricor Enterprises Holdings Limited provided preliminary consolidated earnings guidance for the year ended 31 March 2022. For the year, the group expects to record a net profit of not less than HKD 20 million as compared to the net loss of approximately HKD 12.7 million for the corresponding period last year. The Board considered that the turnaround from loss to profit position of the Group for the year was mainly attributable to the increase in revenue due to steady recovery in local economy and strong rebound in the medical aesthetic industry and the implementation of effective market promotions which increase the public awareness for the brands.